Announcement (October 28, 2009):
StemCells has entered into an agreement to raise gross proceeds of approximately $12.5 million in a registered direct offering.
StemCells will issue approximately 10 million shares of its common stock to selected institutional investors at a price of $1.25 per share. The investors will also receive warrants to purchase approximately 4 million shares of common stock at an exercise price of $1.50 per share.
StemCells retained Chardan Capital Markets, LLC as placement agent in connection with the offering.
The offering is expected to close on November 2, 2009.
Deal Value (US$ Million) 12.5 Deal Type Private Placement Sub-Category None Deal Status Completed: 2009-11-03
Deal Participants
Target (Company) StemCells, Inc. (Formerly CytoTherapeutics, Inc.) Acquirer (Company) Undisclosed Investors
Deal Rationale
StemCells intends to use the net proceeds of the financing for general corporate purposes, including working capital, product development and capital expenditures, as well as for other strategic purposes.
Offer Price ($ per share) 1.25 No. Shares Issued 10000000

More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index